Development of the Implantable Cardioverter-Defibrillator

Maron, Barry J.; Estes, N.A. Mark; Rowin, Ethan J.; Maron, Martin S.; Reynolds, Matthew R.

doi:10.1016/j.jacc.2023.04.056

Cited by 10 publications

(2 citation statements)

References 101 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, it is important to recognize an understandable reticence on the part of pediatricians and other clinicians to obligate healthy appearing young patients to lifelong device implants. However, to underutilize the ICD in high-risk children and adolescents could represent a lost opportunity to elicit the power of this transformative and lifesaving technology now available for over 30 years, 49 capable of delivering the long-standing aspiration of reducing SD events in HCM once considered the most common cause of SD in the young.…”

Section: Discussionmentioning

confidence: 99%

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

Bonaventura¹,

Maron²,

Berul³

et al. 2023

Heart Rhythm O2

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

Bonaventura¹,

Maron²,

Berul³

et al. 2023

Heart Rhythm O2

Self Cite

View full text Add to dashboard Cite

“…The implantable cardioverter-defibrillator (ICD) stands as a sophisticated and miniaturized device with the remarkable ability to automatically sense and terminate life-threatening ventricular arrhythmias. This cutting-edge technology plays a pivotal role in preventing arrhythmic sudden cardiac death (SCD) and has proven to be a lifesaving intervention for thousands of patients globally [1]. Phantom shocks represent a perplexing and underexplored occurrence among patients with ICDs [2,3].…”

Section: Introductionmentioning

confidence: 99%

Understanding Phantom Shocks in Implantable Cardioverter-Defibrillator Recipients

Galo,

Feroze,

Almas

et al. 2024

Cureus

View full text Add to dashboard Cite

Phantom shocks in implantable cardioverter-defibrillator (ICD) recipients create a complex nexus between cardiac treatment and psychological distress. These sensations, mimicking therapeutic shocks without device activation, deeply affect patients' functionality and well-being. Heightened anxiety, depression, and hopelessness predispose individuals to these occurrences, posing significant challenges. This article delves into the intricate nature of phantom shocks, highlighting subtle clinical cues to differentiate them from genuine therapy shocks. Through a case study of a 75-year-old male with recurrent ICD shocks, diagnosed eventually with phantom shocks, the interplay between psychological distress and physical sensations is underscored. Urgent intervention to address the patient's anxiety and depression using psychotherapy and antidepressants became imperative. The case underscores the immense psychological toll of phantom shocks, exacerbating fear, hopelessness, and post-traumatic stress disorder (PTSD). Despite treatment attempts, their impact persisted, leading to a shift to comfort-focused care. While research identifies factors such as education levels and prior therapy, predicting and managing phantom shocks remains challenging. This article stresses the need for clinician vigilance, urging proactive identification and tailored interventions to mitigate the profound effects of phantom shocks. The current research landscape lacks comprehensive strategies, necessitating further exploration and targeted therapies to restore patient well-being. In conclusion, comprehensive understanding and specialized care for phantom shocks in ICD recipients, addressing both cardiac and psychological aspects, are imperative. Early recognition and tailored interventions offer promise in alleviating their adverse effects, reinstating patient control, and improving their quality of life.

show abstract

Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023

Maron,

Rowin,

Maron

2024

The American Journal of Cardiology

View full text Add to dashboard Cite

Development of the Implantable Cardioverter-Defibrillator

Cited by 10 publications

References 101 publications

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

Understanding Phantom Shocks in Implantable Cardioverter-Defibrillator Recipients

Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023

Contact Info

Product

Resources

About